Drug
Defibrotide
Defibrotide: highest development phase Phase 3, developed by Jazz Pharmaceuticals, United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Jazz Pharmaceuticals, United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Defibrotide NCT00358501 | Phase 3 | Severe Hepatic Veno-Occlusive Disease |
| defibrotide NCT00003966 | Phase 2 | Veno-occlusive Disease |
Latest
No recent events.
Follow Defibrotide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.